Trials / Withdrawn
WithdrawnNCT03951662
Immunology of HIV and Alcoholic Hepatitis
Effects of Alcoholic Hepatitis on Immunological and Virological Profiles in HIV-Positive Patients
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is prospective, longitudinal cohort study involving HIV-positive, antiretroviral (ART)-treated, heavy alcohol drinking participants who have and do not have alcoholic hepatitis.
Detailed description
The primary objective of this study is to determine the relationships between alcohol consumption and HIV-related pathogenic processes (microbial translocation, immune activation, inflammation, HIV replication, and hepatitis). Two study groups will be assembled and followed longitudinally over one year to address this objective. Group 1 will include HIV-positive, ART-treated, heavy alcohol drinkers who have alcoholic hepatitis. Group 2 will include HIV-positive, ART-treated, heavy alcohol drinkers who do not have alcoholic hepatitis. Both groups will undergo similar study procedures and follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Alcoholic Hepatitis Group | Alcoholic hepatitis is defined as having a total bilirubin level \>3mg/dL and AST level\>50U/L |
| OTHER | Heavy Drinking Controls without Hepatitis | Normal levels of AST, ALT and total bilirubin and without evidence of cirrhosis or hepatosplenomegaly |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2020-09-30
- Completion
- 2020-09-30
- First posted
- 2019-05-15
- Last updated
- 2021-01-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03951662. Inclusion in this directory is not an endorsement.